Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-025818
Filing Date
2024-08-09
Accepted
2024-08-09 15:04:00
Documents
72
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q krbp20240630_10q.htm   iXBRL 10-Q 1413771
2 EXHIBIT 10.5 ex_710259.htm EX-10.5 8770
3 EXHIBIT 31.1 ex_681151.htm EX-31.1 12310
4 EXHIBIT 31.2 ex_681152.htm EX-31.2 12390
5 EXHIBIT 32.1 ex_681153.htm EX-32.1 5230
6 EXHIBIT 32.2 ex_681154.htm EX-32.2 5286
  Complete submission text file 0001437749-24-025818.txt   6664330

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA krbp-20240630.xsd EX-101.SCH 51453
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krbp-20240630_cal.xml EX-101.CAL 34662
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krbp-20240630_def.xml EX-101.DEF 393203
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE krbp-20240630_lab.xml EX-101.LAB 308420
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krbp-20240630_pre.xml EX-101.PRE 421843
75 EXTRACTED XBRL INSTANCE DOCUMENT krbp20240630_10q_htm.xml XML 1186612
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39619 | Film No.: 241192134
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)